We are live on ! Find out more
ORGO icon

Organogenesis Holdings

31 hedge funds and large institutions have $266M invested in Organogenesis Holdings in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

17% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 6

15% more funds holding

Funds holding: 2731 (+4)

3% more capital invested

Capital invested by funds: $259M → $266M (+$7M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
31
Holders Change
+4
Holders Change %
+14.81%
% of All Funds
0.71%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
6
Increased
7
Reduced
6
Closed
2
Calls
$65.5M
Puts
Net Calls
+$65.5M
Net Calls Change
+$44.7M
Name Holding Trade Value Shares
Change
Change in
Stake
CCA
26
Castle Creek Arbitrage
Colorado
$796K +$795K +79,806 New
HCMT
27
Highland Capital Management (Texas)
Texas
$323K +$321K +32,282 New
PPA
28
Parametric Portfolio Associates
Washington
$180K +$179K +18,000 New
TRCT
29
Tower Research Capital (TRC)
New York
$40K +$19.9K +1,997 +98%
UBS Group
30
UBS Group
Switzerland
$1K +$996 +100 New
ACPU
31
Arrowgrass Capital Partners (US)
Delaware
-$17.8M -1,793,000 Closed
HIM
32
HGC Investment Management
Ontario, Canada
-$1.06M -106,728 Closed
Morgan Stanley
33
Morgan Stanley
New York
-$1.99K -200 -99%

ORGO Hedge Fund Activity: Q1 2018 in Review

31 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q1 2018, worth a combined $266M — up 2.7% from $259M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new ORGO positions and 2 closed out — a net gain of 4 holders — while 7 added to existing stakes and 6 trimmed.

The largest buyer was Bank of Montreal, opening a new position worth an estimated $12M. The largest seller was Arrowgrass Capital Partners (US), exiting entirely with an estimated $17.8M sold.

  • 31 institutional investors held Organogenesis Holdings (ORGO) as of Q1 2018, up from 27 in Q4 2017.
  • Funds reported $266M of Organogenesis Holdings stock for Q1 2018, up 2.7% quarter-over-quarter.
  • 6 funds opened new Organogenesis Holdings positions in Q1 2018 and 2 closed out, a net change of +4 holders.
  • The largest Organogenesis Holdings buyer in Q1 2018 was Bank of Montreal, an estimated $12M added.
  • The largest Organogenesis Holdings seller in Q1 2018 was Arrowgrass Capital Partners (US), an estimated $17.8M sold.

Based on aggregated 13F filings for Q1 2018.